Activator-Mediated Pyruvate Kinase M2 Activation Contributes to Endotoxin Tolerance by Promoting Mitochondrial

Zhujun Yi1, Yilin Wu1, Wenfeng Zhang1

  • 1Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.

Frontiers in Immunology
|February 5, 2021
PubMed

Insights

TEPP-46 activates pyruvate kinase M2 (PKM2) to induce macrophage endotoxin tolerance via mitochondrial biogenesis. This metabolic reprogramming offers a potential therapeutic strategy for sepsis and inflammatory diseases.

Area of Science:

  • Immunology
  • Metabolic pathways
  • Cellular biology

Background:

  • Pyruvate kinase M2 (PKM2) is a key glycolytic enzyme with incompletely understood roles in macrophages.
  • Macrophage activation and inflammatory responses are critical in sepsis and endotoxemia.

Purpose of the Study:

  • To elucidate the role of PKM2 in macrophage endotoxin tolerance.
  • To investigate the underlying mechanisms of PKM2-mediated immune modulation.

Main Methods:

  • PKM2 activation using TEPP-46 in macrophages and mice.
  • Assessment of inflammatory markers (TNF-α, IL-6) and immune response.
  • Analysis of mitochondrial biogenesis and key regulatory pathways (PGC-1α, PI3K/Akt).
  • Gene knockdown studies (mtTFA, PKM2, PGC-1α).

Main Results:

  • TEPP-46 activated PKM2, induced tetramer formation, and promoted macrophage endotoxin tolerance.
  • TEPP-46-induced tolerance was linked to increased mitochondrial biogenesis, regulated by PGC-1α.
  • Inhibition of mitochondrial biogenesis or PGC-1α abolished TEPP-46-mediated tolerance.
  • TEPP-46 administration protected mice from lethal endotoxemia and sepsis.

Conclusions:

  • PKM2 activation by TEPP-46 induces endotoxin tolerance through PGC-1α-mediated mitochondrial biogenesis.
  • This study reveals a novel metabolic pathway for controlling inflammation.
  • Targeting PKM2 presents a promising therapeutic avenue for sepsis and inflammatory conditions.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.7K
Pyruvate Oxidation01:15

Pyruvate Oxidation

After glycolysis, the charged pyruvate molecules enter the mitochondria via active transport and undergo three enzymatic reactions. These reactions ensure that pyruvate can enter the next metabolic pathway so that energy stored in the pyruvate molecules can be harnessed by the cells.
First, the enzyme pyruvate dehydrogenase removes the carboxyl group from pyruvate and releases it as carbon dioxide. The stripped molecule is then oxidized and releases electrons, which are then picked up by NAD+...
166.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.1K
Fates of Pyruvate01:20

Fates of Pyruvate

Pyruvate is the end product of glycolysis, where glucose is oxidized to pyruvate, simultaneously reducing NAD+ to NADH. Two molecules of ATP are also produced by substrate-level phosphorylation.
In aerobic organisms, pyruvate is metabolized via the citric acid cycle to produce reduced coenzymes NADH and FADH2. These coenzymes are then oxidized in the electron transport chain to produce ATP and, in the process, regenerate the NAD+ and FAD. As seen in some cell types and organisms, fermentation...
9.8K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
17.0K
Translocation of Proteins into the Mitochondria01:19

Translocation of Proteins into the Mitochondria

Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
10.1K